Диссертация (1154338), страница 38
Текст из файла (страница 38)
– Vol. 594, № 2. – P. 281-293.334. Ca(2+)-mediated regulation of VDAC1 expression levels is associated withcell death induction / S. Weisthal [et al.] // Biochim. Biophys. Acta. – 2014. –Vol. 1843,№ 10. – P. 2270-2281.335. Calcium channel blockers ameliorate iron overload-associated hepaticfibrosis by altering iron transport and stellate cell apoptosis / Y. Zhang [et al.] //Toxicol. Appl. Pharmacol.
– 2016. – Vol. 301. – P. 50-60.336. Calcium channel blockers in reduction of epidural fibrosis and duraladhesions in laminectomy rats / Z. Wang [et al.] // Eur. J. Orthop. Surg. Traumatol. –2014. – Vol. 24, № 1. – P. 293-298.337. Calcium channel blockers prevent endothelial cell activation in response tonecrotic trophoblast debris: possible relevance to pre-eclampsia / Q. Chen [et al.] //Cardiovasc.
Res. – 2012. – Vol. 96, № 3. – P. 484-93.338. Calcium/calmodulin-dependent kinase IV controls glucose-induced Irs2expression in mouse beta cells via activation of cAMP response element-binding protein/ S. J. Persaud [et al.] // Diabetologia. – 2011. – Vol. 54, № 5. – P. 1109-1120.239339. Calreticulin regulates transforming growth factor-β-stimulated extracellularmatrix production / K.
A. Zimmerman [et al.] // J. Biol. Chem. – 2013. – Vol. 288, №20. – P. 14584-14598.340. CaMK II targets Bcl10 in T-cell receptor induced activation of NF-κB / S.R. Oruganti [et al.] // Mol. Immunol. – 2011. – Vol. 48, № 12. – P. 1448-1460.341. CaMK IV phosphorylates prohibitin 2 and regulates prohibitin 2-mediatedrepression of MEF2 transcription / L. Sun [et al.] // Cell. Signal. – 2011. – Vol.
23, №10. – P. 1686-1690.342. Capon, A. Laser-assisted skin healing (LASH) in hypertrophic scar revision/ A. Capon, G. Iarmarcovai, S. Mordon // J. Cosmet. Laser Ther. – 2009. – Vol. 11, №4. – P. 220-223.343. CD147 promotes IKK/IκB/NF-κB pathway to resist TNF-inducedapoptosis in rheumatoid arthritis synovial fibroblasts / Y.
Zhai [elt al.] // J. Mol. Med(Berl). – 2016. – Vol. 94, № 1. – P. 71-82.344. Cellular and molecular mediators of intestinal fibrosis [Electronic resource]/ I. C. Lawrance [et al.] // J. Crohns Colitis. – 2015. – PII: j.crohns.2014.09.008.345. Chou, T. C. New mechanisms of antiplatelet activity of nifedipine, an Ltype calcium channel blocker [Electronic resource] / T. C. Chou // BioMedicine. – 2014.– DOI: 10.7603/s40681-014-0024-z.346. Combinationtherapywithbutyrateanddocosahexaenoicacidfor keloid fibrogenesis: an in vitro study / K. Torii [et al.] // An.
Bras. Dermatol. – 2017.–Vol. 92, № 2. – P. 184-190.347. Comparison between the intraoperative use of polyvinyl chloride cover andsurgical compresses for preventing postoperative adhesions / C. Akyol [et al.] // Eur.Surg. Res. – 2013. – Vol. 50, № 1. – P. 44-55.348. Comparison of the mechanisms of intralesional steroid, interferon orverapamil injection in the treatment of proliferative scars / S. J. Xu [et al.] // ZhonghuaZheng Xing Wai Ke Za Zhi. – 2009.
– Vol. 25, № 1. – P. 37-40.240349. Connective Tissue Growth Factor (CTGF/CCN2) is Essential forSecondary Palatogenesis / J. Tarr [et al.] // The FASEB J. – 2015. – Vol. 29, № 1, suppl.– P. 872.8.350. Consensus recommendations on adhesions (version 2014) for the ESGEAdhesions Research Working Group (European Society for Gynecological Endoscopy):an expert opinion / R. L. De Wilde [et al.] // Arc. Gynecol. Obstet. – 2014.
– Vol. 290,№ 3. – P. 581-582.351. Control of apoptosis by the BCL-2 protein family: implications forphysiology and therapy / P. E. Czabotar [et al.] // Nat. Rev. Mol. Cell Biol. – 2014. –Vol. 15, № 1. – P. 49-63.352. Current strategies and future perspectives for intraperitoneal adhesionprevention / C. Brochhausen [et al.] // J. Gastrointest. Surg. – 2012. – Vol. 16, № 6. – P.1256-1274.353.
Currently known risk factors for hypertrophic skin scarring: a review / L.Butzelaar [et al.] // J. Plast. Reconst. Aesthet. Surg. – 2016. – Vol. 69, № 2. – P. 163169.354. Darougheh, A. Intralesional triamcinolone alone or in combination with 5fluorouracil for the treatment of keloid and hypertrophic scars / A. Darougheh // Clin.Exp. Dermatol. – 2009. – Vol.
34, № 2. – P. 219-223.355. Dell’Atti, L. Tadalafil once daily and intralesional verapamil injection: Anew therapeutic direction in Peyronie's disease / L. Dell’Atti // Urol. Ann. – 2015. –Vol. 7, № 3. – P. 345.356. Differential apoptosis markers in human keloids and hypertrophic scarsfibroblasts / B.
De Felice [et al.] // Mol. Cell Biochem. – 2009. – Vol. 327, № 1-2. – P.191-201.357. Discoveryanddevelopmentofavotermin(recombinanthumantransforming growth factor beta 3): a new class of prophylactic therapeutic for theimprovement of scarring / N.
L. Occleston [et al.] // Wound Repair. Regen. – 2011. –Vol. 19, suppl. 1. – P. s38-48.241358. Disruption of calcium signaling in fibroblasts and attenuation ofbleomycin-induced fibrosis by nifedipine / S. Mukherjee [et al.] // Am. J. Resp. CellMol. Biol. – 2015. – Vol. 53, № 4. – P. 450-458.359. Diversity of fibroblasts – a review on implications for skin tissueengineering / S. Nolte [et al.] // Cells Tissues Organs. – 2008. – Vol. 187, № 3. – P.165-176.360. Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histonedeacetylase inhibition in human breast cancer cells / S. Ohya [et al.] // Pharmacol.
Res.Perspect. – 2016. – Vol. 4, № 2. – P. e00228.361. Duran-Salgado, M. B. Diabetic nephropathy and inflammation / M. B.Duran-Salgado, A. F. Rubio-Guerra // World J. Diabetes. – 2014. – Vol. 5, № 3. – P.393-398.362. Dynamics of transforming growth factor beta signaling in wound healingand scarring / K.
W. Finnson [et al.] // Adv. Wound care. – 2013. – Vol. 2, № 5. – P.195-214.363. Eddy, A. A. Overview of the cellular and molecular basis of kidney fibrosis/ A. A. Eddy // Kidney int. suppl. – 2014. – Vol. 4, № 1. – P. 2-8.364. Effect of a calcium-channel blocker (verapamil) on the morphology,cytoskeleton and collagenase activity of human skin fibroblasts / R. F. Boggio [et al.] //Burns. – 2011. – Vol.
37, № 4. – P. 616-625.365. Effect of heparin on production of transforming growth factor (TGF)-beta1and TGF-beta1 mRNA expression by human normal skin and hyperplastic scarfibroblasts / S. Q. Fan [et al.] // Ann. Plast. Surg. – 2008. – Vol. 60, № 3. – P. 299-305.366. Effect of reactive oxygen species scavengers, antiinflammatory drugs, andcalcium-channel blockers on carbon dioxide pneumoperitoneumenhanced adhesions in alaparoscopic mouse model / M.M. Binda [et al.] // Surg. Endosc. – 2007.
– Vol. 21, №10. – P. 1826-1834.367. Effect of tetrandrine on the TGF-β-induced smad signal transductionpathway in human hypertrophic scar fibroblasts in vitro / L. Zunwen [et al.] // Burns. –2012. – Vol. 38, № 3. – P. 404-413.242368. Effects of cyclosporin, phenytoin, and nifedipine on the synthesis anddegradation of gingival collagen in tufted capuchin monkeys (Cebus apella):histochemical and MMP-1 and -2 and collagen I gene expression analyses / C.
M.Kanno [et al.] // J. Periodontol. – 2008. – Vol. 79, № 1. – P. 114-22.369. Effects of genistein on expression of TGF-beta1 and intracellular free Ca2+concentration in fibroblasts derived from human hypertrophic scar / C. Cao [et al.] //Zhonghua Zheng Xing Wai Ke Za Zhi. – 2008. – Vol. 24, № 5. – P. 335-338.370. Effectsofmethyleneblue,pentoxyphyllineandenoxaparinonpostoperative adhesion formation and markers of angiogenesis in a rat uterine hornmodel / A.
Boztosun [et al.] // Clin. Exp. Obstet. Gynecol. – 2012. – Vol. 39, № 1. – P.89-95.371. Effects of osthole on apoptosis and TGF-beta1 of hypertrophic scarfibroblasts / X. H. Hou [et al.] // J. Asian Nat. Prod. Res. – 2009. – Vol. 11, № 7. – P.663-669.372. Effects of parecoxib on the prevention of postoperative peritonealadhesions in rats / W. Arung [et al.] // J. Invest. Surg. – 2013.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
